Location History:
- Hull, GB (2007 - 2008)
- London, GB (2006 - 2014)
Company Filing History:
2 out of 263 
1 out of 8 
1 out of 1 Years Active: 2006-2014
Title: Innovations and Contributions of Inventor Geoffrey Wells
Introduction
Geoffrey Wells is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of proliferative diseases. With a total of 4 patents to his name, Wells has established himself as a key figure in medical innovation.
Latest Patents
Wells' latest patents include the development of alkyl 4- [4- (5-oxo-2,3,5, 11a-tetrahydo-5H-pyrrolo [2, 1-c] [1,4] benzodiazepine-8-yloxy)-butyrylamino]-1H-pyrrole-2-carboxylate derivatives and related compounds. This compound is designed for the treatment of proliferative diseases and features a complex structure that allows for various modifications. Another significant patent involves 2-arylbenzothiazole derivatives, which can exist in different forms, including N-oxide or S-oxide, and are also aimed at providing therapeutic benefits.
Career Highlights
Throughout his career, Geoffrey Wells has worked with prominent organizations such as Cancer Research Technology Limited and Spirogen Sarl. His work in these companies has contributed to advancements in cancer research and drug development, showcasing his commitment to improving healthcare outcomes.
Collaborations
Wells has collaborated with notable colleagues, including Andrew David Westwell and Tracey Dawn Poole. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.
Conclusion
Geoffrey Wells is a distinguished inventor whose work has significantly advanced the treatment of proliferative diseases. His innovative patents and collaborations reflect his dedication to improving medical science and patient care.